Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_assertion type Assertion NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_head.
- NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_assertion description "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_provenance.
- NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_assertion evidence source_evidence_literature NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_provenance.
- NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_assertion SIO_000772 12733714 NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_provenance.
- NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_assertion wasDerivedFrom befree-20150227 NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_provenance.
- NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_assertion wasGeneratedBy ECO_0000203 NP972415.RAbt4Up15MVptjltW0S8D-tUv9eNRDYpiNfvF8aVRyksw130_provenance.